Stroke Virtual Grand Rounds
A Woman with Patent Foramen
Ovale and Ischemic Stroke
 |
||
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Release Date: September 27, 2011
Expiration Date: September 27, 2013
Estimated Time of Completion: 1 hour
Description
The purpose of this activity is to provide an in-depth analysis of treatment approaches to mitigate stroke risk in migraineurs with patent foramen ovale (PFO), comparing the use of closure devices with antiplatelet and anticoagulant therapies.
Learning Objectives
- Discuss the etiology of PFO.
- Describe the association between PFO, migraine, stroke, and other vascular ischemic events.
- Evaluate the role of closure devices vs medical therapy in selecting the optimal approach for patients with PFO.
Target Audience
This activity is directed to neurologists, primary care physicians, and other healthcare professionals who manage patients with cerebrovascular disease.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
Edward Manno, MD
Head, Neurocritical Care Unit
Cleveland Clinic
Cleveland, Ohio
Faculty
Dara G. Jamieson, MD
Associate Professor of Neurology and Neurosciences
Weill Cornell Medical College
Associate Attending Neurologist
New York-Presbyterian Hospital
New York, New York
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they have no relationships which, in the context of their presentation, could be perceived as potential conflicts of interest:
Edward Manno, MD
Dara G. Jamieson, MD
All other planners, CME staff, and content reviewers have no relevant financial relationships to disclose.
The Cleveland Clinic Foundation Center for Continuing Education acknowledges
an educational grant for support of this activity from:
Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership
This CME activity was produced by the
Cleveland Clinic Center for Continuing Education
and
